Pe Alterar Data
AstraZeneca 24.63 0.71 2026-09
Genmab 16.04 1.05 2026-06
GlaxoSmithKline 9.72 0.9 2026-09
GRIFOLS 13.04 1.66 2026-09
Hikma Pharmaceutical 10.43 3.72 2025-12
Lakefront Biotherapeutics 2.68 0.14 2026-06
Qiagen NV 23.09 6.37 2026-09
UCB 29.7 5.52 2025-12